New strategies to facilitate the delivery of guideline-recommended care for type 2 diabetes prevention and management will be the topic of the 2024 symposium from Diabetes Care®, the premier clinical research journal of the American Diabetes Association® (ADA).
The Final Frontier—Implementing the Learning From Implementation Science will be held on Saturday, June 22, from 8:00 a.m. – 9:30 a.m. ET in Room W308 of the Orange County Convention Center and be available on-demand on the virtual meeting platform for registered meeting participants following the 84th Scientific Sessions.
“We felt it was time for the journal to focus its annual symposium on implementation science,” said Diabetes Care Editor-in-Chief Steven E. Kahn, MB, ChB. “Experts in the field were selected to provide insights from their work on how we might close the gap to facilitate more widespread uptake of proven health interventions by those delivering care and making health policy. They have also written a wonderful review that will further inform us on the best ways forward.”
The newly published review article, “The Final Frontier in Diabetes Care: Implementing Research in Real-World Practice,” describes successful implementation projects in diabetes prevention, glycemic control, and risk reduction for diabetes-related complications and offers practical strategies to improve the clinical implementation of best practices.
The symposium, chaired by Diabetes Care Deputy Editor John B. Buse, MD, PhD, of the University of North Carolina School of Medicine, will open with an update on diabetes prevention from Brian Oldenburg, MPsychol, PhD, of La Trobe University and Baker Heart and Diabetes Institute. Next, Diabetes Care Associate Editor Matthew J. Crowley, MD, MHS, of Duke University School of Medicine, will discuss the successful use of telehealth to improve diabetes management in real-world practice. A third presentation, by Associate Editor Jennifer B. Green, MD, also of the Duke University School of Medicine, will describe the COORDINATE-Diabetes randomized trial of interventions to reduce cardiovascular risk and improve cardiovascular outcomes. Nisa M. Maruthur, MD, MHS, of Johns Hopkins University School of Medicine, will then offer commentary on future directions, followed by a question and discussion period.
Get On-Demand Access to the Scientific Sessions
There is still time to register for on-demand access to learn about the latest advances in diabetes research, prevention, and care presented at the 84th Scientific Sessions. Select session recordings will be available through Aug. 26.